 |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: October 2025
Volume 10 | Issue 10
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 10
Issue Published : 113
Article Submitted : 18006
Article Published : 7746
Total Authors : 20484
Total Reviewer : 747
Total Countries : 140
Indexing Partner
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | ANTIVIRAL PEPTIDES AS THERAPEUTIC DRUG FOR COVID-19: REVIEW |
| Authors Name: | Navya Lakshmi |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJRTI_184615
|
| Published Paper Id: | IJRTI2211048 |
| Published In: | Volume 7 Issue 11, November-2022 |
| DOI: | |
| Abstract: | Covid-19 is life threatening viral disease caused by SARS-COV2 which caused disaster in human life. Initially, non-availability of vaccines and drugs, virus viability remains a major problem for causing diseases in humans. The use of antiviral peptides (AVPs) as a drug are made from natural sources which are highly effective against the corona virus with minimum side effects and cost-effective therapeutic treatment. Antimicrobial peptides (AMPs) are made from immune system which are suitable for development of new peptide based antiviral drug. Design of antiviral peptides and its potential use against corona, antimicrobial peptides, classes of AMPs, synthetic peptides, novel antiviral therapy, biomedical applications and challenges and future prospects are mainly focused and discussed in this paper. |
| Keywords: | Covid-19, SARS-Cov-2 Antiviral peptide, antimicrobial peptides, Drug therapy |
| Cite Article: | "ANTIVIRAL PEPTIDES AS THERAPEUTIC DRUG FOR COVID-19: REVIEW", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.7, Issue 11, page no.335 - 339, November-2022, Available :http://www.ijrti.org/papers/IJRTI2211048.pdf |
| Downloads: | 000205048 |
| ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: IJRTI2211048
Registration ID:184615
Published In: Volume 7 Issue 11, November-2022
DOI (Digital Object Identifier):
Page No: 335 - 339 Country: Ludhiana, Punjab, India Research Area: Life Sciences Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2211048 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2211048 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijrti.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED,
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Join RMS/Earn 300
WhatsApp
Click Here
Click Here
Indexing Partner |
|||
| Copyright © 2025 - All Rights Reserved - IJRTI | |||